Patient Engagement Solutions Market

Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) - Global Forecast to 2027

Report Code: HIT 2767 May, 2022, by marketsandmarkets.com

The patient engagement solutions market is projected to reach USD 27.9 billion by 2027, at a CAGR of 10.0% during the forecast period. The factors driving the growth of this market are implementation of changing government regulations and healthcare initiatives to promote patient-centric care, high demand for patient engagement solutions in the post pandemic era, and the growing utilization of m-health apps.However, interoperability for patient engagement solutions and a shortage of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period.

Patient Engagement Solutions Market

To know about the assumptions considered for the study, Request for Free Sample Report

Patient Engagement Solutions Market Growth Dynamics

Drivers: Implementation of government regulations and initiatives to promote patient-centric care

In March 2020, the US President signed a USD 2 million coronavirus emergency stimulus package called the CARES (Coronavirus Aid, Relief, and Economic Security) Act. The law expands cover treatment and services for those affected by COVID-19. The CARES Act also increases flexibility for Medicare to cover telehealth services; authorizes Medicare certification for home health services by physician assistants, nurse practitioners, and certified nurse specialists; and increases Medicare payments for COVID-19-related hospital stays and durable medical equipment. Such initiatives/regulations are expected to increase further the demand and adoption of patient engagement solutions in major markets worldwide.

Restraints: Large investment requirements for healthcare infrastructure

Payers have made substantial investments in infrastructure and proprietary systems in the past. Moving or integrating these systems with patient engagement solutions will pose various challenges to these organizations in terms of cost. It will also require changes to their current systems that are optimized to handle only their current requirements. Also, the move to cloud-based patient engagement solutions would involve changing the current IT architecture, especially in hospitals that already serve as hubs connecting multiple physicians, labs, and pharmacists. Hence, finding the resources to achieve large-scale interoperability and interconnectivity could hamper the transition to cloud-based patient engagement solutions for such healthcare institutions.

Challenges: High deployments costs of healthcare IT systems

Healthcare IT systems have high-priced software solutions.The maintenance and software update costs of these systems may be more than the software price. Support and maintenance services along with software upgrades , represent a recurring expenditure, which amounts to almost 30% of the total cost of ownership. The lack of internal skilled  IT professionals  in the healthcare industry necessitates training for end users to increase the efficiency and results of various healthcare IT solutions, thereby adding to the cost of ownership of the systems. Evaluating information systems in healthcare can also be challenging as the organizational impact & benefits of IT systems in healthcare are often intangible.

Opportunities: Growth opportunities in emerging markets

Several factors, such as adopting  government initiatives that  support the adoption of HCIT solutions, rising government expenditure on healthcare facilities, and the presence of skilled IT experts in emerging Asian countries, such as China and India, are expected to support the growth of the patient engagement solutions market in the APAC region. Technological advancements play a key role in reforming the country’s healthcare management sector. China is currently facing challenges such as underfunded rural health centers, overburdened city hospitals, and a nationwide shortage of doctors.

North America accounted for the largest share of the global patient engagement solutions market in 2021.

In 2021, North America accounted for the largest share of the global market. Government regulations supporting the healthcare system, the need to reduce healthcare costs for better accessibility, the rising prevalence of chronic diseases, and the majority of key market players operating in the region are the key factors driving the growth of the market in North America.

Patient Engagement Solutions Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Patient Engagement Solutions Market Key Players

Some of the key players are IBM (US), McKesson Corporation (US), Allscripts (US), Cerner Corporation (US), Epic Systems Corporation (US), Orion Health (New Zealand), GetWellNetwork (US), athenahealth (US), Oneview Healthcare (Ireland), MEDITECH (US), IQVIA (US), Get Real Health (US), Cognizant (US), Symphony Care (US), Harris Healthcare (US), Kareo (US), CureMD Healthcare (US), eClinicalWorks (US), and Lincor Solutions (US), AdvancedMD (US), WellStack(US), IQVIA (US), Vivify Health (US), Medhost (US), Validic (US) MEDISYSINC (US), and  Patient point LLC (US). These players are increasingly focusing on new product launches and partnerships to expand their product offerings in the patient engagement solutions market.

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size available for years

2020-2027

Base year considered

2021

Forecast period

2022–2027

Forecast units

Value (USD Billion)

Segments covered

Component, Delivery Mode, Therapeutic Area, Application, Functionality, End User,And Region

Geographies covered

North America (US, and Canada), Europe (Germany, France, UK, Italy, Spain, and the RoE), Asia Pacific (Japan, China, India, and RoAPAC), RoW (Latin America and Middle East & Africa)

Companies covered

IBM (US), McKesson Corporation (US), Allscripts (US), Cerner Corporation (US), Epic Systems Corporation (US), Orion Health (New Zealand), GetWellNetwork (US), athenahealth (US), Oneview Healthcare (Ireland), MEDITECH (US), IQVIA (US), Get Real Health (US), Cognizant (US), Symphony Care (US), Harris Healthcare (US), Kareo (US), CureMD Healthcare (US), eClinicalWorks (US), and Lincor Solutions (US), AdvancedMD (US), WellStack(US), IQVIA (US), Vivify Health (US), Medhost (US), Validic (US) MEDISYSINC (US), and  Patient point LLC (US)

The study categorizes the Patient engagement solutions market into the following segments and subsegments:

By component

  • Hardware
  • Software
  • Standalone Software
  • Integrated Software
  • Services

By Delivery Mode

  • PREMISE Mode
  • CLOUD-BASED Mode

By Application

  • Health management
  • Home health management
  • Social
  • Financial health management

By Therapeutic area

  • Chronic diseases
  • Cardiovascular diseases (CVD)
  • Diabetes
  • Obesity
  • Other chronic diseases
  • Women’s health
  • Fitness
  • Other Therapeutic Areas

By Funtionality

  • Introduction
  • E-Prescribing
  • Virtual Consultation
  • Patient/Client Scheduling
  • Document Management

By End user

  • Providers
  • Payers 
  • Patients
  • Other End users

By Region,

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • ROW
    • Latin America
    • Middle East & Africa

Recent Developments:

  • In 2021, McKesson (US) announced a strategic agreement with Merck (US) that enables the two healthcare leaders to harness the power of real-world evidence (RWE) toward the common goal of improving patient outcomes and the quality of cancer care.
  • In 2021, Humana (US) collaborated with IBM (US) to deploy IBM Watson Assistant for Health Benefits; it is an AI-enabled virtual agent built in the IBM Watson Health Cloud. This agent helps provide a better member experience while providing greater clarity and transparency on benefits and other related matters for Humana Employer Group members.
  • In 2021, Allied Digestive Health (ADH) selected athenahealth’s (US) cloud-based healthcare payments and patient engagement solutions to drive patient relations and revenue cycle excellence, thus supporting the organization’s growth in the coming years.

      Frequently Asked Questions (FAQ):

      To speak to our analyst for a discussion on the above findings, click Speak to Analyst

    TABLE OF CONTENTS

    1 INTRODUCTION (Page No. - 27)
        1.1 OBJECTIVES OF THE STUDY
        1.2 MARKET DEFINITION
               1.2.1 PATIENT ENGAGEMENT SOLUTIONS MARKET: INCLUSIONS & EXCLUSIONS
        1.3 MARKET SCOPE
               1.3.1 MARKETS COVERED
               1.3.2 YEARS CONSIDERED FOR THE STUDY
        1.4 CURRENCY
        1.5 LIMITATIONS
               1.5.1 SCOPE-RELATED LIMITATIONS
               1.5.2 METHODOLOGY-RELATED LIMITATIONS
        1.6 STAKEHOLDERS
        1.7 SUMMARY OF CHANGES

    2 RESEARCH METHODOLOGY (Page No. - 32)
        2.1 RESEARCH DATA
               FIGURE 1 RESEARCH DESIGN
               2.1.1 SECONDARY DATA
                        2.1.1.1 Key data from secondary sources
               2.1.2 PRIMARY RESEARCH
        2.2 PRIMARY SOURCES
               2.2.1 KEY INDUSTRY INSIGHTS
               2.2.2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
        2.3 MARKET SIZE ESTIMATION METHODOLOGY
               FIGURE 2 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
        2.4 MARKET ESTIMATION
               2.4.1 RESEARCH METHODOLOGY: MARKET ESTIMATION
               2.4.2 APPROACH: END USER-BASED MARKET ESTIMATION
                        FIGURE 3 RESEARCH METHODOLOGY: MARKET ESTIMATION
               2.4.3 TOP-DOWN APPROACH: CONTRIBUTION-BASED MARKET SIZE ESTIMATION
               2.4.4 PATIENT ENGAGEMENT SOLUTIONS MARKET: TOP-DOWN APPROACH
               2.4.5 GROWTH FORECAST
                        FIGURE 4 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE LABORATORY INFORMATICS MARKET (2022–2027)
               FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
        2.5 MARKET DATA ESTIMATION AND TRIANGULATION
               FIGURE 6 DATA TRIANGULATION METHODOLOGY
        2.6 ASSUMPTIONS FOR THE STUDY
        2.7 RISK ASSESSMENT
               TABLE 1 RISK ASSESSMENT: PATIENT ENGAGEMENT SOLUTIONS MARKET
        2.8 LIMITATIONS

    3 EXECUTIVE SUMMARY (Page No. - 45)
        FIGURE 7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION)
        FIGURE 8 GLOBAL MARKET, BY DELIVERY MODE, 2022 VS. 2027 (USD MILLION)
        FIGURE 9 GLOBAL MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
        FIGURE 10 GLOBAL MARKET, BY THERAPEUTIC AREA, 2022 VS. 2027 (USD MILLION)
        FIGURE 11 GLOBAL MARKET, BY FUNCTIONALITY, 2022 VS. 2027 (USD MILLION)
        FIGURE 12 GLOBAL MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
        FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL MARKET

    4 PREMIUM INSIGHTS (Page No. - 51)
        4.1 PATIENT ENGAGEMENT SOLUTIONS MARKET OVERVIEW
               FIGURE 14 RISING GOVERNMENT INITIATIVES FOR PATIENT-CENTRIC CARE DRIVE THE MARKET GROWTH
        4.2 GLOBAL MARKET, BY END USER
               FIGURE 15 PROVIDERS ACCOUNTED FOR THE LARGEST SHARE OF THE GLOBAL MARKET IN 2021
        4.3 NORTH AMERICA: MARKET, BY DELIVERY MODE & COUNTRY (2021)
               FIGURE 16 ON-PREMISE SOLUTIONS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2021
        4.4 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL MARKET
               FIGURE 17 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD

    5 MARKET OVERVIEW (Page No. - 55)
        5.1 INTRODUCTION
        5.2 MARKET DYNAMICS
               FIGURE 18 PATIENT ENGAGEMENT SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
               5.2.1 DRIVERS
                        5.2.1.1 Implementation of government regulations and initiatives to promote patient-centric care
                        5.2.1.2 Increasing adoption of patient engagement solutions
                        5.2.1.3 Rising number of collaborations and partnerships between stakeholders
                                   TABLE 2 INDICATIVE LIST OF COLLABORATIONS BETWEEN ORGANIZATIONS FROM 2020 TO 2022
                        5.2.1.4 Increasing utilization of mobile health apps
               5.2.2 RESTRAINTS
                        5.2.2.1 Large investment requirements for healthcare infrastructure
                        5.2.2.2 Protection of patient information
                        5.2.2.3 Inadequate interoperability across healthcare providers
                        5.2.2.4 Shortage of skilled IT professionals in the healthcare industry
               5.2.3 OPPORTUNITIES
                        5.2.3.1 Growth opportunities in emerging markets
                        5.2.3.2 Wearable health technology
                        5.2.3.3 Cloud-computing solutions
               5.2.4 CHALLENGES
                        5.2.4.1 High deployments costs of healthcare IT systems
                        5.2.4.2 Low levels of healthcare literacy
        5.3 IMPACT OF COVID-19 ON THE PATIENT ENGAGEMENT SOLUTIONS MARKET
        5.4 CASE STUDIES
               5.4.1 FOCUS ON REDUCING READMISSION RATES AND IMPROVING CARE
                        5.4.1.1 Case 1: Need to reduce patient hospital stays
               5.4.2 IMPROVE OUTPATIENT COMMUNICATION
                        5.4.2.1 Case 2: Rising need to curb miscommunication with discharged patients
               5.4.3 PATIENT ENGAGEMENT STRATEGY
                        5.4.3.1 Case 3: Post-discharge care
        5.5 ECOSYSTEM ANALYSIS
               FIGURE 19 PATIENT ENGAGEMENT SOLUTIONS MARKET: ECOSYSTEM ANALYSIS
        5.6 TECHNOLOGY ANALYSIS
               TABLE 3 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS
        5.7 REGULATORY ANALYSIS
               5.7.1 HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT OF 1996 (HIPAA)
               5.7.2 HEALTH INFORMATION TECHNOLOGY FOR ECONOMIC AND CLINICAL HEALTH ACT OF 2009 (HITECH)
               5.7.3 CONSUMER PRIVACY PROTECTION ACT OF 2017
               5.7.4 NATIONAL CYBERSECURITY PROTECTION ADVANCEMENT ACT OF 2015
               5.7.5 CYBERSECURITY LAW OF THE PEOPLE’S REPUBLIC OF CHINA
               5.7.6 AFFORDABLE CARE ACT, 2010
        5.8 PRICING ANALYSIS
        5.9 PORTER’S FIVE FORCES ANALYSIS
               TABLE 4 PATIENT ENGAGEMENT SOLUTION MARKET: PORTER’S FIVE FORCES ANALYSIS
        5.10 INDUSTRY TRENDS
               5.10.1 RISING NEED FOR INTEROPERABILITY & INTEGRATION OF HCIT SOLUTIONS
               5.10.2 GRADUAL SHIFT OF ACCOUNTABILITY FROM PAYERS TO PROVIDERS
               5.10.3 GROWING DEMAND FOR VALUE-BASED HEALTHCARE

    6 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT (Page No. - 70)
        6.1 INTRODUCTION
               TABLE 5 GLOBAL MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
        6.2 HARDWARE
               6.2.1 HARDWARE SOLUTIONS ARE AN INTERACTIVE EXPERIENCE FOR PATIENTS & FAMILIES
                        TABLE 6 HARDWARE MARKET, BY REGION, 2020–2027 (USD MILLION)
        6.3 SOFTWARE
               TABLE 7 SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION)
               TABLE 8 SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
               6.3.1 STANDALONE SOFTWARE
                        6.3.1.1 Standalone software refers to the traditional software installed in client systems
                                   TABLE 9 STANDALONE SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION)
               6.3.2 INTEGRATED SOFTWARE
                        6.3.2.1 Reduction in time spent on data management is driving the growth of this segment
                                   TABLE 10 INTEGRATED SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION)
        6.4 SERVICES
               6.4.1 THE SERVICES SEGMENT IS EXPECTED TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD
                        TABLE 11 SERVICES MARKET, BY REGION, 2020–2027(USD MILLION)

    7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE (Page No. - 76)
        7.1 INTRODUCTION
               TABLE 12 GLOBAL MARKET, BY DELIVERY MODE, 2020–2027(USD MILLION)
        7.2 ON-PREMISE MODE
               7.2.1 PATIENT DATA SAFETY AND COST BENEFITS OF ON-PREMISE DELIVERY MODES TO DRIVE THE MARKET GROWTH
                        TABLE 13 ON-PREMISE MODE MARKET, BY REGION, 2020–2027(USD MILLION)
        7.3 CLOUD-BASED MODE
               7.3.1 REGULATORY REQUIREMENTS HAVE DRIVEN HEALTHCARE PROVIDERS TO ADOPT CLOUD-BASED SOLUTIONS
                        TABLE 14 CLOUD-BASED MODE MARKET, BY REGION, 2020–2027(USD MILLION)

    8 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION (Page No. - 80)
        8.1 INTRODUCTION
               TABLE 15 GLOBAL MARKET, BY APPLICATION, 2020–2027(USD MILLION)
        8.2 HEALTH MANAGEMENT
               8.2.1 HEALTH MANAGEMENT PLAYS A CRUCIAL TOOL IN GUIDING PATIENTS IN SELF-CARE
                        TABLE 16 GLOBAL MARKET FOR HEALTH MANAGEMENT, BY REGION, 2020–2027(USD MILLION)
        8.3 HOME HEALTH MANAGEMENT
               8.3.1 GROWING PREFERENCE FOR HOME HEALTHCARE TO SUPPORT THE MARKET GROWTH
                        TABLE 17 GLOBAL MARKET FOR HOME HEALTH MANAGEMENT, BY REGION, 2020–2027(USD MILLION)
        8.4 SOCIAL & BEHAVIORAL MANAGEMENT
               8.4.1 GROWING POPULARITY OF SOCIAL MEDIA TO DRIVE THE MARKET GROWTH
                        TABLE 18 GLOBAL MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT, BY REGION, 2020–2027(USD MILLION)
        8.5 FINANCIAL HEALTH MANAGEMENT
               8.5.1 FINANCIAL ENGAGEMENT SOLUTIONS HELP PROVIDERS MANAGE PATIENT PAYMENTS
                        TABLE 19 GLOBAL MARKET FOR FINANCIAL HEALTH MANAGEMENT, BY REGION, 2020–2027(USD MILLION)

    9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA (Page No. - 85)
        9.1 INTRODUCTION
               TABLE 20 GLOBAL MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
        9.2 CHRONIC DISEASES
               TABLE 21 GLOBAL MARKET FOR CHRONIC DISEASES, BY REGION, 2020–2027 (USD MILLION)
               TABLE 22 GLOBAL MARKET FOR CHRONIC DISEASES, BY TYPE, 2020–2027 (USD MILLION)
               9.2.1 CARDIOVASCULAR DISEASES (CVD)
                        9.2.1.1 CVD is the leading cause of death worldwide
                                   TABLE 23 GLOBAL MARKET FOR CVD, BY REGION, 2020–2027 (USD MILLION)
               9.2.2 DIABETES
                        9.2.2.1 The high incidence of diabetes worldwide drives the growth of this segment
                                   TABLE 24 GLOBAL MARKET FOR DIABETES, BY REGION, 2020–2027 (USD MILLION)
               9.2.3 OBESITY
                        9.2.3.1 Rising prevalence of obesity to drive the growth of this segment
                                   TABLE 25 GLOBAL MARKET FOR OBESITY, BY REGION, 2020–2027 (USD MILLION)
               9.2.4 OTHER CHRONIC DISEASES
                        TABLE 26 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY REGION, 2020–2027 (USD MILLION)
        9.3 WOMEN’S HEALTH
               9.3.1 INCREASING SELF AWARENESS FOR THE MANAGEMENT OF DISEASES TO DRIVE THE MARKET GROWTH
                        TABLE 27 GLOBAL MARKET FOR WOMEN’S HEALTH, BY REGION, 2020–2027 (USD MILLION)
        9.4 FITNESS
               9.4.1 GROWING PREFERENCE FOR A HEALTHY LIFESTYLE TO SUPPORT THE MARKET GROWTH FOR FITNESS-RELATED APPS
                        TABLE 28 GLOBAL MARKET FOR FITNESS, BY REGION, 2020–2027 (USD MILLION)
        9.5 OTHER THERAPEUTIC AREAS
               TABLE 29 GLOBAL MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2020–2027 (USD MILLION)

    10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY (Page No. - 93)
         10.1 INTRODUCTION
               TABLE 30 GLOBAL MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION)
                 10.1.1 E-PRESCRIBING
                            10.1.1.1 E-prescribing is a cost-effective method of providing valuable information to clinicians to enhance decision-making
                                         TABLE 31 GLOBAL MARKET FOR E-PRESCRIBING, BY REGION, 2020–2027 (USD MILLION)
                 10.1.2 VIRTUAL CONSULTATION
                            10.1.2.1 Telehealth provides flexibility in treatment options due to remote monitoring
                                         TABLE 32 GLOBAL MARKET FOR VIRTUAL CONSULTATION, BY REGION, 2020–2027 (USD MILLION)
                 10.1.3 PATIENT/CLIENT SCHEDULING
                            10.1.3.1 Patient/client scheduling enables physicians to streamline workflows and efficiently manage patient schedules
                                         TABLE 33 GLOBAL MARKET FOR PATIENT/CLIENT SCHEDULING, BY REGION, 2020–2027 (USD MILLION)
                 10.1.4 DOCUMENT MANAGEMENT
                            10.1.4.1 The effective management of patient documents is crucial for healthcare providers
                                         TABLE 34 GLOBAL MARKET FOR DOCUMENT MANAGEMENT, BY REGION, 2020–2027 (USD MILLION)

    11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER (Page No. - 98)
         11.1 INTRODUCTION
               TABLE 35 GLOBAL MARKET, BY END USER, 2020–2027 (USD MILLION)
         11.2 PROVIDERS
                 11.2.1 PROVIDERS ARE THE LARGEST END USERS OF PATIENT ENGAGEMENT SOLUTIONS
                            TABLE 36 GLOBAL MARKET FOR PROVIDERS, BY REGION, 2020–2027 (USD MILLION)
         11.3 PAYERS
                 11.3.1 PATIENT ENGAGEMENT SOLUTIONS HELP HEALTHCARE PAYERS MINIMIZE ERRORS
                            TABLE 37 GLOBAL MARKET FOR PAYERS, BY REGION, 2020–2027 (USD MILLION)
         11.4 PATIENTS
                 11.4.1 PATIENT ENGAGEMENT SOLUTIONS MOTIVATE INDIVIDUALS TO MONITOR & IMPROVE HEALTH OUTCOMES
                            TABLE 38 GLOBAL MARKET FOR PATIENTS, BY REGION, 2020–2027 (USD MILLION)
         11.5 OTHER END USERS
               TABLE 39 GLOBAL MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)

    12 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION (Page No. - 103)
         12.1 INTRODUCTION
                 TABLE 40 GLOBAL MARKET, BY REGION, 2020–2027(USD MILLION)
         12.2 NORTH AMERICA
                 FIGURE 20 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
                 TABLE 41 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                 TABLE 42 NORTH AMERICA: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                 TABLE 43 NORTH AMERICA: MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                 TABLE 44 NORTH AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
                 TABLE 45 NORTH AMERICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                 TABLE 46 NORTH AMERICA: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                 TABLE 47 NORTH AMERICA: MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION)
                 12.2.1 US
                            12.2.1.1 The US is the largest market in North America for patient engagement solutions in 2022
                                         TABLE 48 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                         TABLE 49 US: MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                                         TABLE 50 US: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                         TABLE 51 US: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                         TABLE 52 US: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                 12.2.2 CANADA
                            12.2.2.1 Growing need for cost containment to propel the market growth in Canada
                                         TABLE 53 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                         TABLE 54 CANADA: MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                                         TABLE 55 CANADA: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                         TABLE 56 CANADA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                         TABLE 57 CANADA: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
         12.3 EUROPE
                 TABLE 58 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                 TABLE 59 EUROPE: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                 TABLE 60 EUROPE: MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                 TABLE 61 EUROPE: MARKET, BY END USER, 2020–2027 (USD MILLION)
                 TABLE 62 EUROPE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                 TABLE 63 EUROPE: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                 TABLE 64 EUROPE: MARKET, BY FUNCTIONALITY, 2020–2027(USD MILLION)
                 12.3.1 GERMANY
                            12.3.1.1 Germany is the largest market for patient engagement solutions in Europe in 2022
                                         TABLE 65 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                         TABLE 66 GERMANY: MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                                         TABLE 67 GERMANY: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                         TABLE 68 GERMANY: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                         TABLE 69 GERMANY: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                 12.3.2 FRANCE
                            12.3.2.1 Digital health insurance startups in France to drive the market growth for patient engagement solutions
                                         TABLE 70 FRANCE: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                         TABLE 71 FRANCE: MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                                         TABLE 72 FRANCE: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                         TABLE 73 FRANCE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                         TABLE 74 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                 12.3.3 UK
                            12.3.3.1 Favorable government initiatives to promote healthcare to support market growth in the UK
                                         TABLE 75 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                         TABLE 76 UK: MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                                         TABLE 77 UK: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                         TABLE 78 UK: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                         TABLE 79 UK: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                 12.3.4 SPAIN
                            12.3.4.1 Data security concerns restrict the market growth in Spain
                                         TABLE 80 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                         TABLE 81 SPAIN: MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                                         TABLE 82 SPAIN: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                         TABLE 83 SPAIN: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                         TABLE 84 SPAIN: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                 12.3.5 ITALY
                            12.3.5.1 The growing burden of chronic diseases in Italy drives the demand for patient engagement solutions
                                         TABLE 85 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                         TABLE 86 ITALY: MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                                         TABLE 87 ITALY: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                         TABLE 88 ITALY: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                         TABLE 89 ITALY: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                 12.3.6 REST OF EUROPE (ROE)
                            TABLE 90 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                            TABLE 91 ROE: MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                            TABLE 92 ROE: MARKET, BY END USER, 2020–2027 (USD MILLION)
                            TABLE 93 ROE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                            TABLE 94 ROE: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
         12.4 ASIA PACIFIC
                 FIGURE 21 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
                 TABLE 95 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                 TABLE 96 ASIA PACIFIC: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                 TABLE 97 ASIA PACIFIC: MARKET, BY DELIVERY MODE, 2020–2027(USD MILLION)
                 TABLE 98 ASIA PACIFIC: MARKET, BY END USER, 2020–2027 (USD MILLION)
                 TABLE 99 ASIA PACIFIC: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                 TABLE 100 ASIA PACIFIC: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                 TABLE 101 ASIA PACIFIC: MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION)
                 12.4.1 JAPAN
                            12.4.1.1 The rising geriatric population in Japan supports the market growth for patient engagement solutions
                                         TABLE 102 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                         TABLE 103 JAPAN: MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                                         TABLE 104 JAPAN: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                         TABLE 105 JAPAN: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                         TABLE 106 JAPAN: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                 12.4.2 CHINA
                            12.4.2.1 Implementation of EMR solutions in healthcare by the Chinese government is expected to drive the demand for patient engagement solutions
                                         TABLE 107 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                         TABLE 108 CHINA: MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                                         TABLE 109 CHINA: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                         TABLE 110 CHINA: MARKET, BY APPLICATION, 2020–2027 USD MILLION)
                                         TABLE 111 CHINA: MARKET, BY THERAPEUTIC AREA, 2020–2027(USD MILLION)
                 12.4.3 INDIA
                            12.4.3.1 High burden of chronic diseases to support the market growth for patient engagement solutions
                                         TABLE 112 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                         TABLE 113 INDIA: MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                                         TABLE 114 INDIA: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                         TABLE 115 INDIA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                         TABLE 116 INDIA: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                 12.4.4 REST OF ASIA PACIFIC (ROAPAC)
                            TABLE 117 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                            TABLE 118 ROAPAC: MARKET, BY DELIVERY MODE, 2020–2027(USD MILLION)
                            TABLE 119 ROAPAC: MARKET, BY END USER, 2020–2027 (USD MILLION)
                            TABLE 120 ROAPAC: MARKET, BY APPLICATION, 2020–2027(USD MILLION)
                            TABLE 121 ROAPAC: MARKET, BY THERAPEUTIC AREA, 2020–2027(USD MILLION)
         12.5 REST OF THE WORLD
                 TABLE 122 REST OF THE WORLD: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION)
                 TABLE 123 ROW: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                 TABLE 124 ROW: MARKET, BY DELIVERY MODE, 2020–2027(USD MILLION)
                 TABLE 125 ROW: MARKET, BY END USER, 2020–2027 (USD MILLION)
                 TABLE 126 ROW: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                 TABLE 127 ROW: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                 TABLE 128 ROW: MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION)
                 12.5.1 LATIN AMERICA
                            12.5.1.1 Developments in healthcare infrastructure to support the market growth
                                         TABLE 129 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                         TABLE 130 LATIN AMERICA: MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                                         TABLE 131 LATIN AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                         TABLE 132 LATIN AMERICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                         TABLE 133 LATIN AMERICA: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                 12.5.2 MIDDLE EAST & AFRICA
                            12.5.2.1 Rising government support to drive the market growth for patient engagement solutions in the MEA
                                         TABLE 134 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                         TABLE 135 MIDDLE EAST & AFRICA: MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                                         TABLE 136 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2020–2027(USD MILLION)
                                         TABLE 137 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                         TABLE 138 MIDDLE EAST & AFRICA: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)

    13 COMPETITIVE LANDSCAPE (Page No. - 150)
         13.1 OVERVIEW
         13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
                 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE PATIENT ENGAGEMENT SOLUTIONS MARKET
         13.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
                 FIGURE 22 REVENUE ANALYSIS OF KEY PLAYERS IN THE GLOBAL MARKET
         13.4 MARKET RANKING
                 FIGURE 23 GLOBAL MARKET RANKING, BY KEY PLAYER, 2021
         13.5 COMPETITIVE BENCHMARKING
                 TABLE 139 GLOBAL MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
                 TABLE 140 GLOBAL MARKET: DETAILED LIST OF KEY STARTUP/SMES
         13.6 COMPETITIVE LEADERSHIP MAPPING
                 13.6.1 STARS
                 13.6.2 EMERGING LEADERS
                 13.6.3 PERVASIVE PLAYERS
                 13.6.4 PARTICIPANTS
                            FIGURE 24 PATIENT ENGAGEMENT SOLUTIONS MARKET (GLOBAL) COMPANY EVALUATION MATRIX, 2021
         13.7 COMPETITIVE LEADERSHIP MAPPING – START-UP/SME
                 13.7.1 PROGRESSIVE COMPANIES
                 13.7.2 STARTING BLOCKS
                 13.7.3 RESPONSIVE COMPANIES
                 13.7.4 DYNAMIC COMPANIES
                            FIGURE 25 COMPETITIVE LEADERSHIP MAPPING, START-UP/SME MATRIX MARKET
         13.8 COMPETITIVE SITUATIONS AND TRENDS
                 13.8.1 PRODUCT LAUNCHES
                 13.8.2 DEALS

    14 COMPANY PROFILES (Page No. - 166)
         14.1 KEY PLAYERS
    (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))* 
                 14.1.1 IBM
                            TABLE 141 IBM: BUSINESS OVERVIEW
                            FIGURE 26 IBM: COMPANY SNAPSHOT (2021)
                 14.1.2 MCKESSON CORPORATION
                            TABLE 142 MCKESSON CORPORATION: BUSINESS OVERVIEW
                            FIGURE 27 MCKESSON CORPORATION: COMPANY SNAPSHOT (2021)
                 14.1.3 ALLSCRIPTS HEALTHCARE SOLUTIONS INC
                            TABLE 143 ALLSCRIPTS HEALTHCARE SOLUTIONS INC: BUSINESS OVERVIEW
                            FIGURE 28 ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2021)
                 14.1.4 ATHENAHEALTH
                            TABLE 144 ATHENAHEALTH: BUSINESS OVERVIEW
                 14.1.5 ORION HEALTH
                            TABLE 145 ORION HEALTH: BUSINESS OVERVIEW
                 14.1.6 CERNER CORPORATION
                            TABLE 146 CERNER: BUSINESS OVERVIEW
                            FIGURE 29 CERNER CORPORATION: COMPANY SNAPSHOT (2021)

                            TABLE 147 GETWELL NETWORK INC: BUSINESS OVERVIEW
                 14.1.8 LINCOR SOLUTIONS
                            TABLE 148 LINCOR SOLUTIONS: BUSINESS OVERVIEW
                 14.1.9 COGNIZANT
                            TABLE 149 COGNIZANT: BUSINESS OVERVIEW
                            FIGURE 30 COGNIZANT: COMPANY SNAPSHOT (2020)
                 14.1.10 HARRIS HEALTHCARE
                            TABLE 150 HARRIS HEALTHCARE: BUSINESS OVERVIEW
         14.2 OTHER KEY PLAYERS
                 14.2.1 GET REAL HEALTH
                 14.2.2 ONEVIEW HEALTHCARE
                 14.2.3 ADVANCEDMD
                 14.2.4 EPIC SYSTEMS CORPORATION
                 14.2.5 MEDITECH
                 14.2.6 KAREO
                 14.2.7 ECLINICAL WORKS
                 14.2.8 WELLSTACK
                 14.2.9 IQVIA
                 14.2.10 VIVIFY HEALTH
                 14.2.11 MEDHOST
                 14.2.12 VALIDIC
                 14.2.13 CUREMD HEALTHCARE
                 14.2.14 MEDISYSINC.COM
                 14.2.15 PATIENTPOINT, LLC
    *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies. 

    15 APPENDIX (Page No. - 204)
         15.1 DISCUSSION GUIDE
         15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
         15.3 AVAILABLE CUSTOMIZATIONS
         15.4 RELATED REPORTS
         15.5 AUTHOR DETAILS

    This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the Patient Engagement Solutions market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the patient engagement solutions market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

    Secondary Research

    The secondary sources referred to for this research study include publications from government sources, such as WHO, ATA, AHA and AAHM. Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global patient engagement solutions market, which was validated through primary research.  

    Primary Research

    Extensive primary research was conducted after acquiring basic knowledge about the global patient engagement solutions market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (such as Individual Physicians, Physician Groups, Hospitals, Clinics and Other Healthcare Facilities, Payers- Private and Public Insurance Bodies, Other End Users- Employer Groups and Government Bodies) and supply-side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, and channel partners, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, Middle East and the Africa. Approximately 70% and 30% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    Patient Engagement Solutions Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the global patient engagement solutions market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry and markets have been identified through extensive secondary research.
    • The revenue generated from the sale of patient engagement solutions products by leading players has been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Data Triangulation

    After arriving at the overall market size, from the market size estimation process explained above, the patient engagement solutions market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the remote patient monitoring market

    Report Objectives

    • To define, describe, and forecast the global patient engagement solutions market based on component, delivery mode, application, therapeutic area, functionality, end user, and region
    • To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall patient engagement solutions market
    • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To strategically analyze the market structure and profile the key players of the patient engagement solutions market and comprehensively analyze their core competencies
    • To forecast the size of the market segments with respect to four regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa)
    • To track and analyze competitive developments such as product launches, acquisitions, partnerships, agreements, and collaborations in the patient engagement solutions market during the forecast period

    Available Customizations:

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Company information

    • Detailed analysis and profiling of additional market players (up to 20)
    Report Code
    HIT 2767
    Published ON
    May, 2022
    Choose License Type
    BUY NOW
    • SHARE
    X
    Request Customization
    Speak to Analyst
    Speak to Analyst
    OR FACE-TO-FACE MEETING
    PERSONALIZE THIS RESEARCH
    • Triangulate with your Own Data
    • Get Data as per your Format and Definition
    • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
    • Any level of Personalization
    REQUEST A FREE CUSTOMIZATION
    LET US HELP YOU!
    • What are the Known and Unknown Adjacencies Impacting the Patient Engagement Solutions Market
    • What will your New Revenue Sources be?
    • Who will be your Top Customer; what will make them switch?
    • Defend your Market Share or Win Competitors
    • Get a Scorecard for Target Partners
    CUSTOMIZED WORKSHOP REQUEST
    +1-888-600-6441
    • Call Us
    • +1-888-600-6441 (Corporate office hours)
    • +1-888-600-6441 (US/Can toll free)
    • +44-800-368-9399 (UK office hours)
    CONNECT WITH US
    ABOUT TRUST ONLINE
    ©2022 MarketsandMarkets Research Private Ltd. All rights reserved
    DMCA.com Protection Status Website Feedback